Company: INMB
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001213900-25-033742
Chunk: 1

Company: Inmune Bio, Inc.
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 1
---
 Meeting, the holders of the Company’s outstanding capital stock will act on the following matters: 1.To elect five directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified; 2.To ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025; 3.To approve, by non -bindingadvisory vote, the resolution approving named executive officer compensation; 4.To approve, by non -bindingadvisory vote, the frequency of future non -bindingadvisory votes on resolutions approving future named executive officer compensation; and 5.To approve the Second Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan. We also will transact such other business as may properly come before the Meeting and any adjournments or postponements of the Meeting. These matters are more fully described in the proxy statement accompanying this notice. Only holders of the Company’s common stock of record at the close of business on April 14, 2025, are entitled to notice of and to vote at the Meeting. A proxy statement containing important information about the Meeting and the matters voted upon appear on the following pages. The Board of Directors recommends that you vote “FOR” the proposals set forth in this Notice of Annual Meeting of Stockholders and the proxy statement.

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING The Company has enclosed a copy of the proxy statement, the proxy card and the Company’s annual report, as amended to stockholders for the year ended December 31, 2024 (the “Annual Report”). The proxy statement, the proxy card and the Annual Report are also available on the Company’s website at https://www.inmunebio.com/index.php/en/investors/filings. If you have any questions or need assistance voting your shares of our common stock, please contact the Company at (858) 964 -3720.

| /s/ David Moss                        |
| David Moss                            |
| Chief Financial Officer and Secretary |

Boca Raton, FL
April 21, 2025 PLEASE NOTE:The Meeting will be held to tabulate the votes cast and to report the results of voting on the items described above. No other business matters are planned for the Meeting.

TABLE OF CONTENTS

|                                                                                                                                                 |     | Page |
| QUESTIONS AND ANSWERS                                                                                                                           |     |